Author
Listed:
- Ousseny Zerbo
(Kaiser Permanente Northern California, Vaccine Study Center)
- G. Thomas Ray
(Kaiser Permanente Northern California, Vaccine Study Center)
- Bruce Fireman
(Kaiser Permanente Northern California, Vaccine Study Center)
- Evan Layefsky
(Kaiser Permanente Northern California, Vaccine Study Center)
- Kristin Goddard
(Kaiser Permanente Northern California, Vaccine Study Center)
- Edwin Lewis
(Kaiser Permanente Northern California, Vaccine Study Center)
- Pat Ross
(Kaiser Permanente Northern California, Vaccine Study Center)
- Saad Omer
(Yale University, Institute for Global Health
Yale School of Medicine
Yale School of Public Health)
- Mara Greenberg
(Kaiser Permanente Northern California Oakland
Kaiser Permanente Northern California)
- Nicola P. Klein
(Kaiser Permanente Northern California, Vaccine Study Center)
Abstract
We examined the effectiveness of maternal vaccination against SARS-CoV-2 infection in 30,311 infants born at Kaiser Permanente Northern California from December 15, 2020, to May 31, 2022. Using Cox regression, the effectiveness of ≥2 doses of COVID-19 vaccine received during pregnancy was 84% (95% confidence interval [CI]: 66, 93), 62% (CI: 39, 77) and 56% (CI: 34,71) during months 0–2, 0–4 and 0- 6 of a child’s life, respectively, in the Delta variant period. In the Omicron variant period, the effectiveness of maternal vaccination in these three age intervals was 21% (CI: −21,48), 14% (CI: −9,32) and 13% (CI: −3,26), respectively. Over the entire study period, the incidence of hospitalization for COVID-19 was lower during the first 6 months of life among infants of vaccinated mothers compared with infants of unvaccinated mothers (21/100,000 person-years vs. 100/100,000 person-years). Maternal vaccination was protective, but protection was lower during Omicron than during Delta. Protection during both periods decreased as infants aged.
Suggested Citation
Ousseny Zerbo & G. Thomas Ray & Bruce Fireman & Evan Layefsky & Kristin Goddard & Edwin Lewis & Pat Ross & Saad Omer & Mara Greenberg & Nicola P. Klein, 2023.
"Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life,"
Nature Communications, Nature, vol. 14(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36547-4
DOI: 10.1038/s41467-023-36547-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36547-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.